SARAH PEAK: Open Payments
NPI 1457054280 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 16 payments from 7 companies in 2025. Trend: 2023 $32 · 2024 $160 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Novo Nordisk Inc | 4 | $79 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Lundbeck LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: REXULTI, BREZTRI, TRELEGY ELLIPTA, Wegovy, LEQVIO, ZEPBOUND, Rybelsus, MOUNJARO.
Industry payments across WY — which companies pay providers there.
